Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52


Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.

Sempere LF, Preis M, Yezefski T, Ouyang H, Suriawinata AA, Silahtaroglu A, Conejo-Garcia JR, Kauppinen S, Wells W, Korc M.

Clin Cancer Res. 2010 Aug 15;16(16):4246-55. doi: 10.1158/1078-0432.CCR-10-1152. Epub 2010 Aug 3.


Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes.

Jørgensen S, Baker A, Møller S, Nielsen BS.

Methods. 2010 Dec;52(4):375-81. doi: 10.1016/j.ymeth.2010.07.002. Epub 2010 Jul 16.


MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.

Avissar M, McClean MD, Kelsey KT, Marsit CJ.

Carcinogenesis. 2009 Dec;30(12):2059-63. doi: 10.1093/carcin/bgp277.


MicroRNAs in cancer: small molecules with a huge impact.

Iorio MV, Croce CM.

J Clin Oncol. 2009 Dec 1;27(34):5848-56. doi: 10.1200/JCO.2009.24.0317. Epub 2009 Nov 2. Review.


MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.

Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC.

Clin Cancer Res. 2009 Oct 1;15(19):6192-200. doi: 10.1158/1078-0432.CCR-09-1467. Epub 2009 Sep 29.


Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.

Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC.

Clin Cancer Res. 2009 Sep 15;15(18):5878-87. doi: 10.1158/1078-0432.CCR-09-0627. Epub 2009 Sep 8.


MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.

Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E.

Clin Cancer Res. 2009 Jun 15;15(12):3998-4008. doi: 10.1158/1078-0432.CCR-08-3053. Epub 2009 Jun 9.


Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.

Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M, Ichinose M, Shiogama K, Tsutsumi Y, Omata M, Iba H.

Clin Cancer Res. 2009 Jun 15;15(12):4009-16. doi: 10.1158/1078-0432.CCR-08-3257. Epub 2009 Jun 9.


Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

Hawinkels LJ, Verspaget HW, van der Reijden JJ, van der Zon JM, Verheijen JH, Hommes DW, Lamers CB, Sier CF.

Cancer Sci. 2009 Apr;100(4):663-70.


Many roads to maturity: microRNA biogenesis pathways and their regulation.

Winter J, Jung S, Keller S, Gregory RI, Diederichs S.

Nat Cell Biol. 2009 Mar;11(3):228-34. doi: 10.1038/ncb0309-228. Review.


miR-21: a small multi-faceted RNA.

Krichevsky AM, Gabriely G.

J Cell Mol Med. 2009 Jan;13(1):39-53. doi: 10.1111/j.1582-4934.2008.00556.x. Review.


MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK.

Cardiovasc Res. 2009 Apr 1;82(1):21-9. doi: 10.1093/cvr/cvp015. Epub 2009 Jan 15.


MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S.

Nature. 2008 Dec 18;456(7224):980-4. doi: 10.1038/nature07511. Epub 2008 Nov 30.


High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H.

Breast Cancer Res Treat. 2009 Sep;117(1):131-40. doi: 10.1007/s10549-008-0219-7. Epub 2008 Oct 19.


An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation.

Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, Verde P.

Oncogene. 2009 Jan 8;28(1):73-84. doi: 10.1038/onc.2008.370. Epub 2008 Oct 13.


MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.

RNA. 2008 Nov;14(11):2348-60. doi: 10.1261/rna.1034808. Epub 2008 Sep 23.


microRNAs and cancer: an overview.

Medina PP, Slack FJ.

Cell Cycle. 2008 Aug 15;7(16):2485-92. Epub 2008 Aug 17. Review.


Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES.

Clin Chem. 2008 Oct;54(10):1696-704. doi: 10.1373/clinchem.2007.101741. Epub 2008 Aug 21.


MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM.

Mol Cell Biol. 2008 Sep;28(17):5369-80. doi: 10.1128/MCB.00479-08. Epub 2008 Jun 30.


MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.

Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M.

Mol Biol Cell. 2008 Aug;19(8):3272-82. doi: 10.1091/mbc.E08-02-0159. Epub 2008 May 28.

Supplemental Content

Support Center